ACM
RCKT icon

ADAR1 Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

ADAR1 Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Sell
432,500
-43,300
-9% -$172K 0.09% 130
2025
Q4 		$1.67M Sell
475,800
-100,000
-17% -$342K 0.12% 110
2025
Q3 		$1.88M Buy
575,800
+300,000
+109% +$945K 0.19% 81
2025
Q2 		$676K Buy
275,800
+34,000
+14% +$172K 0.11% 101
2025
Q1 		$1.61M Buy
241,800
+30,400
+14% +$300K 0.31% 65
2024
Q4 		$2.66M Buy
211,400
+207,100
+4,816% +$3.12M 0.55% 42
2024
Q3 		$79.4K Buy
4,300
+4,200
+4,200% +$86K 0.01% 196
2024
Q2 		$2.15K Buy
+100
New +$2.3K ﹤0.01% 256

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return